- Featured Product
- KD/KO Validated
GOLGA2/GM130 Monoklonaler Antikörper
GOLGA2/GM130 Monoklonal Antikörper für IF, WB, ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Ratte
Anwendung
WB, IF, ELISA
Konjugation
Unkonjugiert
CloneNo.
2A4F11
Kat-Nr. : 66662-1-Ig
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | LNCaP-Zellen, HEK-293-Zellen, HeLa-Zellen, HepG2-Zellen, Jurkat-Zellen, K-562-Zellen, PC-12-Zellen |
Erfolgreiche Detektion in IF | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunfluoreszenz (IF) | IF : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
WB | See 6 publications below |
Produktinformation
66662-1-Ig bindet in WB, IF, ELISA GOLGA2/GM130 und zeigt Reaktivität mit human, Ratten
Getestete Reaktivität | human, Ratte |
In Publikationen genannte Reaktivität | human, Ratte |
Wirt / Isotyp | Maus / IgG1 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | GOLGA2/GM130 fusion protein Ag1848 |
Vollständiger Name | golgi autoantigen, golgin subfamily a, 2 |
Berechnetes Molekulargewicht | 111 kDa |
Beobachtetes Molekulargewicht | 130 kDa |
GenBank-Zugangsnummer | BC014188 |
Gene symbol | GOLGA2 |
Gene ID (NCBI) | 2801 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-G-Reinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
GOLGA2, also known as GM130, is a 130 kDa cis-Golgi matrix protein which is one component of the detergent and salt resistant Golgi matrix. It is a peripheral membrane protein highly bound to Golgi membrane and localized mainly at the cytoplasmic face of cis-Golgi membrane. Together with its interacting partner proteins, including p115, giantin, GRASP65, and Rab GTPase, GOLGA2/GM130 is involved in the regulation of ER-to-Golgi transport and also in the maintenance of the Golgi structure. Emerging evidence suggest that the GOLGA2/GM130 has potential roles in the control of glycosylation, cell cycle progression, and higher order cell functions such as cell polarization and directed cell migration. (PMID: 20197635)
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for GOLGA2/GM130 antibody 66662-1-Ig | Protokoll herunterladen |
IF protocol for GOLGA2/GM130 antibody 66662-1-Ig | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
J Extracell Vesicles Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. | ||
Mol Metab CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. | ||
Front Mol Biosci Schwann Cell-Derived Exosomes Induce the Differentiation of Human Adipose-Derived Stem Cells Into Schwann Cells. | ||
Anticancer Drugs Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway | ||
Nat Commun Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity | ||
J Mater Sci Mater Med Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |